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30

Abstract

31

Recent studies suggest that chemokines may mediate the luteolytic action of PGF2α (PGF).

32

Our objective was to identify chemokines induced by PGF in vivo and to determine the effects of

33

IL8 on specific luteal cell types in vitro. Midcycle cows were injected with saline or PGF, ovaries

34

were removed after 0.5 - 4 h and chemokine expression was analyzed by qPCR. In vitro

35

expression of IL8 was analyzed after PGF administration and with cell signaling inhibitors to

36

determine the mechanism of PGF-induced chemokine expression. Purified neutrophils were

37

analyzed for migration and activation in response to IL8 and PGF. Purified luteal cell types

38

(steroidogenic, endothelial and fibroblast cells) were used to identify which cells respond to

39

chemokines. Neutrophils and peripheral blood mononuclear cells (PBMCs) were co-cultured

40

with steroidogenic cells to determine their effect on progesterone production. IL8, CXCL2,

41

CCL2, and CCL8 transcripts were rapidly increased following PGF treatment in vivo and. The

42

stimulatory action of PGF on IL8 mRNA expression in vitro was prevented by inhibition of p38

43

and JNK signaling. IL8, but not PGF, TNF, or TGFB1, stimulated neutrophil migration. IL8 had

44

no apparent action in purified luteal steroidogenic, endothelial, or fibroblast cells, but IL8

45

stimulated ERK phosphorylation in neutrophils. In co-culture experiments neither IL8 nor

46

activated neutrophils altered basal or LH-stimulated luteal cell progesterone synthesis. In

47

contrast, activated PBMCs inhibited LH-stimulated progesterone synthesis from cultured luteal

48

cells. These data implicate a complex cascade of events during luteolysis involving chemokine

49

signaling, neutrophil recruitment, and immune cell action within the corpus luteum.

50
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51

Introduction

52
53

The corpus luteum develops after ovulation and secretes progesterone, a steroid hormone

54

essential for the establishment and maintenance of early pregnancy (Niswender et al. 2000,

55

Stocco et al. 2007). In the absence of hormonal cues or pregnancy the corpus luteum will

56

regress in a process termed luteolysis. In many species, luteolysis is mediated by uterine

57

and/or intraluteal release of prostaglandin F2 alpha (PGF) (Davis & Rueda 2002, Wiltbank &

58

Ottobre 2003, Niswender et al. 2007, Bogan et al. 2008). PGF has been shown to act

59

indirectly at the vascular level to cause disruption of luteal capillaries (Maroni & Davis 2011) and

60

apoptosis of capillary endothelial cells (Henkes et al. 2008). PGF has also been implicated in

61

the initiation of luteal cell apoptosis in vivo (Davis & Rueda 2002, Quirk et al. 2013); however,

62

PGF alone cannot directly reduce the viability of luteal cells in vitro (Davis & Rueda 2002,

63

Kawaguchi et al. 2013). Thus, other mechanisms must be activated for luteolysis to proceed

64

through both the functional (loss of progesterone secretion) and structural (apoptosis and tissue

65

remodeling) stages of regression.

66
67

Immune cells and their effector cytokines participate in various reproductive processes (Pate &

68

Landis Keyes 2001, Skarzynski 2008, Shirasuna et al. 2012a, 2012b) including: ovulation

69

(Vinatier et al. 1995, Ujioka et al. 1998), endometrial function (Braundmeier et al. 2012, Care et

70

al. 2013), as well as corpus luteum formation and regression (Erlebacher et al. 2004,

71

Skarzynski 2008, Shirasuna et al. 2012a, 2012b, 2012c, Care et al. 2013). Interleukin 8 (IL8,

72

also known as CXCL8) is a known chemotactic cytokine secreted by a variety of cells in

73

response to inflammatory stimuli. IL8 secretion is implicated in the recruitment and activation of

74

neutrophils (Mukaida 2000, 2003), including within the corpus luteum (Polec et al. 2009,

75

Jiemtaweeboon et al. 2011, Shirasuna et al. 2012a). In rabbits, neutralization of IL8
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76

suppresses neutrophil activation and ovulation (Ujioka et al. 1998). Recent studies also indicate

77

that neutrophils and IL8 are involved in establishment of the corpus luteum following ovulation.

78

IL8 and neutrophils are known to promote angiogenesis (Heidemann et al. 2003, Li et al. 2003)

79

findings which have been recently extended to the developing corpus luteum (Jiemtaweeboon

80

et al. 2011, Nitta et al. 2011, Shirasuna et al. 2012b, 2012c). IL8 is also capable of stimulating

81

progesterone secretion by luteinizing granulosa (Shimizu et al. 2012) and theca cells (Shimizu

82

et al. 2013).

83
84

Our objective was to identify chemokines induced by PGF in vivo and to determine the effect of

85

IL8 on specific luteal cell types in vitro. We also employed co-cultures to evaluate the effects of

86

immune cells on luteal progesterone synthesis. The present study demonstrates that PGF

87

stimulates the expression of IL8, CCL8, CCL2 and CXCL2. While IL8 was effective at

88

recruitment of neutrophils, neither IL8 nor activated neutrophils reduced LH-stimulated luteal

89

progesterone synthesis. In contrast, activated polymorphic mononuclear cells (PBMCs)

90

inhibited LH-stimulated progesterone by luteal cells in vitro. The activation of immune cells

91

during luteolysis may be involved in the regression of the bovine corpus luteum.

92
93

Materials and Methods

94

In vivo Studies

95

All animal procedures were conducted under an IACUC-approved protocol and performed at the

96

University of Nebraska-Lincoln, Animal Sciences Department. Post-pubertal female cattle of

97

composite breeding age were given an intramuscular injection at midcycle (days 9-10) with

98

saline (n = 3) or 25 mg of the PGF analogue, Lutalyse (Pharmacia & Upjohn Company, New

99

York, NY, n = 12). Ovariectomies were performed at 0.5, 1, 2, and 4 h after PGF treatment and

100

RNA was isolated from the corpora lutea using an Absolutely mRNA Purification Kit (Agilent
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101

Technologies Inc., Santa Clara, CA.) according to the manufacturer’s instructions. RNA yields

102

were measured using a fluorescence detection kit (RiboGreen; Invitrogen, Carlsbad, CA).

103

Screening with whole-transcript bovine microarray (Affymetrix, Santa Clara, CA) revealed

104

several chemokines that were induced following treatment with PGF. Quantitative real-time

105

PCR (qPCR) was used to validate changes in IL8, CCL2, CCL8, and CXCL2 mRNA using the

106

primers provided in Table 1. First-strand cDNA was synthesized from 1 µg total RNA using

107

iScriptTM cDNA synthesis kit (Bio-Rad, Hercules, CA) according to the manufacturers'

108

instructions. qPCR was performed using the CFX96TM Real-Time PCR Detection System (Bio-

109

Rad, Hercules, CA) with ssoFastTM EvaGreen® Supermix (Bio-Rad, Hercules, CA) with the

110

following parameters: 95 °C for 30 s followed by 40 cycles of: 95 °C for 5 s, and 55 °C for 5 s.

111

ACTB or GADPH were used as internal standards of mRNA expression. The authenticity of the

112

PCR signal was verified by reactions containing no RNA or reactions omitting reverse

113

transcriptase. Melt curve analysis was performed to ensure amplification of a single product at

114

the predicted melting temperature.

115
116

In vitro Studies

117

All cell culture experiments described below were done in tissue culture plastic (Corning CoStar,

118

Corning, NY) and included penicillin (100 IU/ml, Gibco Life Technologies, Carlesbad, CA)

119

streptomycin (100 µg/ml, Gibco Life Technologies, Carlesbad, CA), and amphotericin (50 µg/ml,

120

MP Biomedicals, Santa Ana, CA) in cell culture medium to prevent bacterial and fungal growth.

121
122

Isolation of Bovine Luteal cells

123

Bovine ovaries were collected from a local abattoir (XL Four Star Beef, Omaha, NE). The tissue

124

was obtained from cows during early pregnancy (fetal crown rump length < 10 cm) to assure

125

luteal function (Ireland et al. 1980). The luteal tissue was dissected from the ovary and
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126

dissociated with 103 IU/mL collagenase (Atlanta Biologicals, Norcross, GA) as described

127

previously (Chakravorty et al. 2013). Luteal cell viability was determined using trypan blue

128

exclusion, and luteal cell preparations with more than 90% viability were used. Enriched bovine

129

steroidogenic luteal cells (1 × 105 cells/cm2) were plated as previously described (Hou et al.

130

2010). Cells were incubated overnight in medium 199 (M199, Lonza, Basel, Switzerland)

131

supplemented with 5% fetal bovine serum (FBS, Valley Biomedical, Winchester, VA). The next

132

day the medium was changed and the incubations were continued for 1 day in FBS-free media.

133

On the day of the experiment, the medium was replaced with fresh FBS-free medium for 2-3 h

134

to pre-equilibrate before applying the treatments detailed in the figure legends.

135
136

Isolation of Bovine Endothelial and Fibroblast cells

137

Endothelial cells were isolated from bovine corpus luteum of early pregnancy and purified as

138

described before (Maroni & Davis 2011). Endothelial cells were positive for vascular endothelial

139

cell cadherin (VE-cadherin) and negative for steroidogenic enzymes and prolyl 4-hydroxylase

140

(antibodies are listed in Table 2). Cells were grown to ~80% confluence in Dulbecco’s Modified

141

Eagle Medium (DMEM, Corning CellGro, Corning, NY) containing 10% FBS and 20 µg/ml

142

endothelial cell growth supplement (ECGS, Millipore, Bedford, MA). The medium was changed

143

to serum-free DMEM containing 20 µg/ml ECGS for 2 h prior to the treatments described in the

144

figure legends.

145
146

Fibroblasts were isolated from the bovine corpus luteum and characterized as previously

147

described (Maroni & Davis 2012). The fibroblasts were positive for prolyl 4-hydroxylase and

148

collagen 1 and negative for steroidogenic enzymes and VE-cadherin (antibodies listed in Table

149

2). Luteal fibroblasts were grown to ~80% confluence and changed to serum-free DMEM for 2

150

h prior to treatment with IL8 as described in the figure legends.
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151
152

Isolation of bovine neutrophils and migration assays

153

Potassium EDTA (Sigma-Aldrich, St. Louis, MO)-anticoagulated bovine blood samples were

154

collected from a local abattoir (XL Four Star Beef, Omaha, NE), centrifuged, and subjected to

155

Percoll gradient (Sigma-Aldrich, St. Louis, MO) separation to isolate neutrophils. The remaining

156

erythrocytes were lysed by rapid treatment with dH2O and the remaining cells were

157

resuspended in Roswell Park Memorial Institute 1640 medium (RPMI, Thermo Fisher Scientific

158

HyClone, Waltham, MA). Cell migration was assayed using the Boyden chamber method.

159

Bovine neutrophils (2.5 x 105) were seeded in transparent PET membrane cell culture inserts

160

with 3 µm pores (B&D Falcon, Franklin Lakes, NJ) placed in 24-well plates. The lower chamber

161

was filled with 500 µl RPMI with or without 30 ng/mL IL8 (R&D Systems, Minneapolis, MN), 100

162

nM PGF2α, 10 ng/ml tumor necrosis factor alpha (TNF, R&D Systems, Minneapolis, MN) or 1

163

ng/ml transforming growth factor beta 1 (TGFB1). Cell migration was carried out for up to 24 h

164

at 37 °C. Migrated cells were counted with a hemacytometer.

165
166

To determine the signaling pathways used by IL8 in bovine neutrophils, we treated neutrophils

167

with IL8 or TNF (R&D Systems, Minneapolis, MN), a modulator of immune function and

168

activator of multiple signaling pathways. Western blot analysis was performed to examine the

169

mitogen-activated protein kinase (ERK1/2, p38 and JNK), AKT and NFκB signaling pathways

170

using phospho-specific antibodies. See Table 2 for a complete list of antibodies used.

171
172

Isolation of human neutrophils and degranulation assays

173

Human neutrophils were isolated from peripheral blood of healthy donors by density gradient

174

centrifugation under an approved IRB at the University of Nebraska Medical Center, using

175

polymorphprep (Axis-Shield, Oslo, Norway) in accordance with manufacturer’s instruction.
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176

Purified neutrophils were re-suspended in RPMI + 5% FBS. Neutrophils (3 x 105 cells) were

177

incubated with different concentrations of IL8 at 37 °C for 1 h. Neutrophil degranulation was

178

examined by florescence-activated cell sorting for increased cell surface expression of granule

179

molecules carcinoembryonic antigen-related cell adhesion molecule 8 (CD66b); and integrin

180

alpha M (CD11b). Cells were stained with fluorescein isothiocynate (FITC)-conjugated mouse

181

anti-human CD66b antibody and allophycocyanin (APC)-conjugated mouse anti-human CD11b

182

antibody on ice for 30 min. After rinsing, cells were fixed with PBS plus 2% formaldehyde. Flow

183

cytometry analysis was done using a Becton Dickinson (Franklin Lakes, NJ) FACSCaliber flow

184

cytometer and was performed at the UNMC Cell and Tissue Analysis Facility.

185
186

Isolation of bovine peripheral blood mononuclear cells

187

Acid citrate dextrose-anticoagulated blood samples from cows were collected from a local

188

abattoir (XL Four Star Beef, Omaha, NE). Blood was then diluted 1:2 in cold Hank’s Balance

189

Salt Solution (HBSS, Corning CellGro, Corning, NY) with 2 mM EDTA (Sigma-Aldrich, St. Louis,

190

MO) and 5% FBS. Diluted blood was underlayed with an equal volume of Histopaque (specific

191

gravity = 1.083, Sigma-Aldrich, St. Louis, MO) and centrifuged at 900 x g for 30 min. PBMCs

192

were collected from interface between the plasma and Histopaque. The cells were then washed

193

in HBSS three times before use.

194
195

Co-culture experiments

196

Enriched bovine steroidogenic luteal cells were plated (∼1 × 105 cells/cm2) in basal M199

197

medium containing 5% FBS in 48-well plates overnight as described above.

198
199

Neutrophil-luteal cell co-culture:
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200

Neutrophils were isolated on the same day that luteal cells were prepared. Purified neutrophils

201

were then cultured in RPMI (10% FBS) with or without 30 ng/ml IL8 and 20 nM phorbol

202

myristate acetate (PMA, EMD Millipore Calbiochem, Billerica, MA) overnight. After 24 h the

203

medium was replaced on the luteal cell cultures. Neutrophils (250,000 cells/ml) were then

204

added to the luteal cells in M199 and RPMI (1:1) with 10% FBS for 2 h before adding control

205

media or 10 ng/ml bLH (Tucker Endocrine Research Institute, Atlanta, GA). Medium from each

206

well was collected 6 hours after LH or control treatments for progesterone analysis.

207
208

PBMC-luteal cell co-culture:

209

Twenty-four hours after plating the luteal cells, the medium was removed from the culture wells

210

and replaced with fresh M199. Then an equal volume of newly isolated bovine PBMCs in RPMI

211

(100,000 cells/ml) were added to the luteal cell culture. Co-cultures were incubated for 24 h in

212

M199 and RPMI (1:1 ratio) + 10% FBS, and with or without 10 µg/ml concavalin A (Sigma, St.

213

Louis, MO) to activate the PBMCs. After 24 h of co-culture, medium was replaced with

214

M199:RPMI + 10% FBS for 2 h to pre-equilibrate the cells before the addition of control media

215

or 10 ng/ml LH. Medium was removed from each well after 6 h of control or LH treatment for

216

progesterone analysis.

217
218

Western blot analysis

219

Cultures of neutrophils, steroidogenic cells, luteal endothelial cells, and luteal fibroblasts were

220

harvested with ice cold cell lysis buffer [20 mM Tris-HCl (pH = 7), 150 mM NaCl, 1 mM

221

Na2EDTA, 1 mM EGTA, 1% Triton X-100 and protease and phosphatase inhibitor cocktails

222

(Sigma-Aldrich, St. Louis, MO)]. Protein concentration was determined and 40-60 µg protein

223

was subjected to 10% SDS-PAGE. After transfer to polyvinylidene fluoride (PVDF) membranes,

224

the membranes were probed with appropriate amounts of primary antibodies and bound
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225

antibodies were detected with a horse radish peroxidase (HRP) conjugated secondary antibody

226

and the Femto Western Blotting Detection Kit (GE Healthcare Amersham, Cleveland, OH).

227

Signals were visualized using a Digital Sciences Image Station 440 (Kodak, Rochester, NY).

228
229

Progesterone Analysis

230

Conditioned media were collected for progesterone determination using Coat-A-Count

231

progesterone RIA kit (Siemens, Deerfield, IL) according to the manufacturer’s instructions and

232

as previously reported (Hou et al. 2010).

233
234

Statistical Analysis

235

All experiments were performed at least two times using different cell preparations with

236

qualitatively comparable results. The data are presented as representative experiments or as

237

the means ± SEM of the averages from multiple experiments. The differences in means were

238

analyzed by t test or ANOVA followed by multiple range testing. P < 0.05 was considered

239

statistically significant.

240
241

Results

242

PGF Stimulates Chemokine Gene Expression In Vivo

243

Treatment with PGF in vivo resulted in a 4.3 ± 1.0-fold increase in IL8 mRNA within 30 min and

244

a 8.9 ± 2.2-fold increase in IL8 mRNA within 1 h of administration (Figure 1A). Treatment with

245

PGF also increased CCL8, CXCL2, and CCL2 mRNA after 1 h (fold increases of 2.5 ± 0.6; 2.9 ±

246

0.7 and 3.1 ± 0.6, respectively). After a brief lag the expression of chemokine mRNA increased

247

dramatically after 4 h of treatment with PGF. A 35 ± 4 fold increase in IL8 mRNA expression

248

was observed in response to a 4 h treatment with PGF. At the 4 h mark PGF also stimulated
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249

significant (P < 0.05) increases in CCL8, CCL2 and CXCL2 mRNA expression (29 ± 3.8, 12 ±

250

1.5 and 6.4 ± 1 fold, respectively).

251
252

PGF Stimulates IL8 Expression In Vitro

253

Treatment of steroidogenic luteal cells with PGF for 1 h in vitro also increased IL8 mRNA

254

expression (2.7 ± 0.3-fold increase, P < 0.05; Figure 1B). Luteal steroidogenic cells were

255

pretreated in the presence or absence of specific inhibitors of the mitogen-activated protein

256

kinase (MAPK) signaling cascade to determine which intracellular signals contribute to the

257

stimulatory effect of PGF on the induction of IL8 gene expression (Figure 1B). Pretreatment

258

with the ERK1/2 inhibitor U0126 (Enzo Life Sciences, Farmingdale, NY) failed to prevent the

259

stimulatory effect of PGF on IL8 mRNA (Figure 1B). In contrast, inhibition of the stress-

260

activated protein kinase p38 MAPK with SB2037580 resulted in a complete inhibition of the

261

response to PGF. Treatment with the JNK inhibitor SP600125 also resulted in a significant

262

inhibition (77%, P < 0.05) of the PGF-induced increase in IL8 mRNA.

263
264

IL8 Induces Migration of Bovine Neutrophils

265

To determine whether IL8 would affect the function of bovine neutrophils, we purified neutrophils

266

from blood collected at slaughter from cows. As shown in Figure 2A neutrophils stained with

267

hematoxylin and eosin had distinct multi-lobular nuclei, a characteristic of neutrophils. A

268

Boyden chamber assay (Figure 2A) was used to determine whether IL8 or other factors

269

produced during luteolysis could increase migration of bovine neutrophils. We observed that

270

treatment for 18 h with 30 ng/ml IL8 caused a 20-fold (P < 0.05) increase in neutrophil

271

migration. However, treatment of neutrophils with 100 nM PGF under identical conditions had

272

no effect on neutrophil migration (Figure 2B). Migration assays were also performed with other

273

chemokines that have been implicated in luteal regression; namely TNF (Henkes et al. 2008,
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274

Skarzynski et al. 2009) and TGFB1 (Maroni & Davis 2011, 2012) . In experiments evaluating

275

neutrophil migration during a 3 h treatment period, we found that 30 ng/ml IL8, but not 100 nM

276

PGF, 10 ng/ml TNF, or 1 ng/ml TGFB1, was capable of stimulating migration of neutrophils

277

(Figure 2C).

278
279

Activation of neutrophils results in the rapid cell surface expression of molecules that allows for

280

endothelium attachment for extravasation. Treatment of human neutrophils with increasing

281

concentrations of human IL8 (0-100 ng/ml) resulted in the rapid expression of the cell adhesion

282

molecules CDIIb (integrin alpha-M0, ITGAM) and CD66b (carcinoembryonic antigen-related cell

283

adhesion molecule 8, CEACAM8) as determined by flow cytometry (not shown).

284
285

IL8 selectively stimulates signaling in bovine neutrophils

286

Treatment with IL8 for 15 min stimulated an increase (5-fold, P < 0.05) in ERK1/2

287

phosphorylation (Figure 3A). The response was transient and returned to control levels within

288

120 min following IL8 treatment (Figures 3A and 5A). IL8 did not stimulate either the p38 or the

289

JNK MAPK signaling pathways (Figure 3A). TNF was used as a positive control since it

290

activates many signaling pathways in immune cells. In contrast to IL8, TNF provoked sustained

291

ERK phosphorylation, as well as p38 and JNK phosphorylation in bovine neutrophils throughout

292

the 120 min investigated (Figure 3A). IL8 exerted a slight, but consistent, increase in the

293

phosphorylation of p65-NFκB and AKT; whereas, TNF stimulated a robust increase in p65 NFkB

294

and AKT phosphorylation in neutrophils. To determine whether IL8 could similarly stimulate

295

other cells of the corpus luteum, we treated bovine luteal fibroblasts, endothelial cells and

296

steroidogenic cells with IL8 under various treatment times and concentrations. IL8 did not

297

stimulate the phosphorylation of AKT, ERK or NFκB in any of these luteal cell types. As a
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298

positive control we observed that TNF stimulated MAPK and NFκB signaling in each cell type

299

examined (data not shown).

300
301

In view of the very prominent effect of IL8 on ERK signaling in neutrophils, we tested whether

302

the IL8-induced increase in ERK phosphorylation was associated with the effect of IL8 on

303

neutrophil migration. Pretreatment with 5 µM of U0126, completely blocked the induction of

304

ERK phosphorylation (Figure 4A), but did not prevent the stimulatory effect of IL8 on bovine

305

neutrophil migration (Figure 4B).

306
307

Effect of IL8 and immune cells on progesterone secretion

308

Experiments were performed to determine whether IL8 altered progesterone secretion.

309

Pretreatment of steroidogenic luteal cells with increasing amounts of IL8 (0-30 ng/ml) did not

310

alter basal or LH-simulated progesterone production in luteal cells (Figure 5A). Next, we co-

311

cultured neutrophils with steroidogenic cells and evaluated the ability of LH to stimulate

312

progesterone secretion. We observed that co-cultures of steroidogenic cells and neutrophils

313

had no effect on the ability of LH to increase progesterone (Figure 5B). Furthermore, co-

314

cultures of steroidogenic cells and activated neutrophils had no effect on basal or LH-stimulated

315

progesterone production.

316
317

Co-cultures of steroidogenic cells and PBMCs had no effect on the ability of LH to secrete

318

progesterone (Figure 6). However, LH-stimulated progesterone production was completely

319

abrogated (P < 0.05) in cultures of activated PBMCs and steroidogenic luteal cells (Figure 6).

320
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321

Discussion

322
323

For over thirty years the immune system has been postulated as essential for fertility (Espey

324

1980). The present study provides additional insight into the expression and function of

325

chemokines during luteal regression. We observed that induction of luteal regression in cows

326

with a bolus of PGF in vivo resulted in a rapid increase in the expression of IL8, CCL8, CCL2,

327

and CXCL2. Our findings confirm recent findings by (Shirasuna et al. 2012a) that PGF treatment

328

of dairy cattle increased luteal IL8 mRNA by approximately 4-fold within 30 min. In that study,

329

the fold increase in IL8 mRNA remained constant over a 12 h of period of treatment with PGF.

330

In the present study using beef cattle we observed more robust increases in luteal IL8 mRNA

331

expression; 9-fold increases within 1 h and 35-fold increases after 4 h of PGF treatment. At

332

present it is not clear whether the differences in the magnitude of the responses are due to

333

differences in the cattle breeds or other factors, because there are reported differences in the

334

responses of beef and dairy cattle to synchronization protocols using PGF (Lucy et al. 2001).

335

Based on the pronounced increase in IL8 expression, it was selected for further analysis. We

336

found that IL8 acted directly on neutrophils but had little effect on other cell types in the mid-

337

cycle corpus luteum. Furthermore, co-cultures of luteal cells with activated neutrophils did not

338

alter LH-stimulated progesterone synthesis; whereas co-cultures with activated PBMCs

339

suppressed LH-stimulated progesterone synthesis.

340
341

Activation of the PGF receptor rapidly induces calcium mobilization and activation of PKC

342

(Davis et al. 1987). These initial signaling events lead to the activation of ERK1/2 (Chen et al.

343

1998, Arvisais et al. 2010), p38, and JNK (Yadav et al. 2002, Yadav & Medhamurthy 2006,

344

Mao et al. 2013) in vivo and in vitro, with subsequent activation of multiple transcription factors.

345

The MAPK signaling family induces early-response genes such as FOS and JUN (Chen et al.
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346

2001), NR4A1 (Stocco et al. 2007, Atli et al. 2012), EGR1 (Hou et al. 2008, Atli et al. 2012),

347

and ATF3 (Mondal et al. 2011, Mao et al. 2013) in the corpus luteum. To determine which

348

intracellular signals contribute to the stimulatory effect of PGF on IL8 gene expression, luteal

349

cells were treated with specific inhibitors of ERK1/2, p38, and JNK. We observed that the

350

ERK1/2 inhibitor U0126 had no effect on IL8 mRNA expression in response to PGF, while the

351

p38 MAPK inhibitor SB2037580 and the JNK inhibitor SP600125 significantly inhibited the PGF-

352

mediated upregulation of IL8 mRNA. The results indicate that the stress-activated MAPKs: p38

353

and JNK play an important and perhaps overlapping role in the induction of IL8 mRNA in

354

response to PGF.

355
356

Chemokines like IL8 are responsible for the recruitment of immune cells to chemokine-

357

producing tissues. Our findings demonstrate that IL8 is chemotactic for bovine neutrophils, in

358

agreement with previous literature (Mukaida 2000, 2003, Jiemtaweeboon et al. 2011,

359

Shirasuna et al. 2012a) . IL8 stimulated a 6-fold increase in neutrophil migration within 3 h and

360

after 24 h IL8-treatment increased neutrophil migration nearly 20-fold. In contrast, treatment

361

with PGF had no effect on neutrophil migration at either time point. These findings are

362

consistent with the studies by (Liptak et al. 2005, Shirasuna et al. 2012a) showing that immune

363

cells are unresponsive to PGF because they do not express the PGF receptor. In the present

364

study we also report that TNF and TGBF1, two cytokines induced rapidly in the bovine corpus

365

luteum in response to PGF and implicated in events associated with luteal regression (Henkes

366

et al. 2008, Hou et al. 2008, Mondal et al. 2011, Maroni & Davis 2012) did not increase the

367

migration of bovine neutrophils in the Boyden chamber assay. Our observations support the

368

recent reports (Sales et al. 2009, Mondal et al. 2011, Atli et al. 2012, Shirasuna et al. 2012a)

369

showing that PGF induces IL8 mRNA and that the expression of IL8 is associated with the

370

appearance of neutrophils in the bovine corpus luteum (Jiemtaweeboon et al. 2011, Shirasuna
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et al. 2012a, 2012b) . In addition, our studies indicate that IL8 stimulates the degranulation of

372

human neutrophils which may be important for their migration from the blood into the corpus

373

luteum. These findings correspond with the studies of Shirasuna et al. (2012a) demonstrating

374

the rapid appearance of P-selectin on endothelial cells following treatment with PGF, which

375

allows for adhesion of neutrophils to endothelial cells. Other chemokines (CCL8, CCL2, and

376

CXCL2) are induced concomitantly with IL8, therefore it will be important to evaluate the

377

contributions of each individual chemokine to the recruitment of specific immune cells into the

378

regressing corpus luteum. Future experiments should also address how combinations of these

379

chemokines signal the recruitment and activation of immune cells within the corpus luteum

380

(Gouwy et al. 2008).

381
382

Treatment of neutrophils with IL8 stimulated a robust increase in ERK phosphorylation, a slight

383

increase in AKT and NFκB phosphorylation, and had no effect on p38 and JNK signaling. In

384

contrast, TNF activated all of these pathways simultaneously in neutrophils. Since ERK

385

signaling was the most prominent pathway activated following IL8 treatment of bovine

386

neutrophils, we determined whether neutrophil migration could be blocked by treatment with the

387

MEK1/2 inhibitor U0126. Interestingly, we found that inhibition of ERK signaling with U0126 had

388

no inhibitory effect on IL8-stimulated neutrophil migration. These results suggest that another

389

signaling pathway is responsible for IL8-stimulated chemotaxis, likely the PI3K and RAC

390

signaling pathway (Neptune et al. 1999, Futosi et al. 2013) . Further studies are required to

391

determine the contributions of other signaling pathways to neutrophil activation and migration.

392
393

IL8 has been shown to induce diverse cellular responses in cells other than neutrophils

394

(Mukaida 2003) . Recent studies suggest that IL8 may contribute to angiogenesis in the newly

395

forming corpus luteum (Jiemtaweeboon et al. 2011) and progesterone secretion by granulosa
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396

(Shimizu et al. 2012) and theca (Shimizu et al. 2013) cells. Treatment with various IL8

397

concentrations and treatment times revealed no changes in cell signaling in steroidogenic cells,

398

endothelial cells, or fibroblasts isolated from the bovine corpus luteum. However, IL8 stimulated

399

a robust increase in ERK phosphorylation in neutrophils. Furthermore, IL8 did not affect basal or

400

LH-stimulated progesterone secretion from cultured luteal cells. In contrast to the findings by

401

Shimizu et al. 2012 using cells from the ovarian follicle, we found no evidence suggesting that

402

IL8 acted directly on bovine luteal cells types that are involved in luteal regression (e.g.,

403

endothelial cells, fibroblasts and steroidogenic cells). Based on these findings it appears that

404

IL8 exerts specific effects on ovarian cell types depending on their stage of differentiation. Given

405

that the corpus luteum is highly differentiated and undergoes regression in response to PGF,

406

the lack of a stimulatory effect of IL8 on angiogenesis and steroidogenesis may be expected

407

since the vasculature and steroid secretion are disrupted during regression (Davis & Rueda

408

2002, Niswender 2002, Stocco et al. 2007, Maroni & Davis 2012). It is possible that during

409

luteal regression IL8-activated neutrophils contribute to phagocytosis during structural

410

regression of the corpus luteum.

411
412

The increase observed in multiple chemokines suggests that immune cells other than

413

neutrophils could be recruited in to the corpus luteum following administration of PGF. In fact,

414

studies from multiple laboratories have demonstrated an increase in neutrophils, T cells, or

415

macrophages during the regression of the corpus luteum in rodents (Kuranaga et al. 1999),

416

rabbits (Krusche et al. 2002), ruminants (Murdoch 1987, Penny et al. 1999), primates

417

(Braundmeier et al. 2012) and women (Wang et al. 1992, Best et al. 1996, Gaytan et al. 1998,

418

Suzuki et al. 1998). A previous report indicated that co-culture of rat neutrophils with luteal cells

419

resulted in a decrease in progesterone secretion, presumably as a result of oxidative stress

420

(Behrman et al. 2001). However, under our experimental conditions co-cultures of bovine
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421

neutrophils and steroidogenic luteal cells did not alter basal or LH-stimulated progesterone

422

synthesis. Treatment of neutrophils with IL8 and PMA, alone or in combination, to activate

423

neutrophils was not sufficient to reduce progesterone secretion under co-culture conditions. In

424

addition to neutrophils, monocytes are immune effector cells that are also equipped with

425

chemokine receptors and adhesion receptors that mediate migration from blood to tissues

426

(Murray & Wynn 2011). Since we observed that PGF rapidly induced the expression of other

427

chemokines (CCL8, CCL2, and CXCL2), which could recruit other types of immune cells, we

428

established a co-culture system with PBMCs and luteal cells. Although, un-activated PBMCs did

429

not reduce progesterone secretion, we observed that activated PBMCs effectively reduced LH-

430

driven progesterone secretion. These observations support our earlier findings (Liptak et al.

431

2005) that activated immune cells may contribute a factor (or factors) that impair

432

steroidogenesis in response to LH. It is known that activated monocytes produce inflammatory

433

cytokines, nitric oxide, and reactive oxygen species (Murray & Wynn 2011, Zhou et al. 2014) all

434

of which may contribute individually or in combination to the inhibition of progesterone synthesis

435

(Al-Gubory et al. 2012, Quirk et al. 2013, Skarzynski et al. 2013). In the in vivo setting,

436

activated monocytes may also secrete matrix metalloproteinases that contribute to the

437

degradation of the extracellular matrix (Murray & Wynn 2011), which could facilitate the

438

recruitment of additional inflammatory cells to the regressing corpus luteum.

439
440

A complex interaction of endocrine and immune cells appears to be required to mediate the

441

structural and functional regression of the bovine corpus luteum. Since chemokines act

442

synergistically to activate their target cells (Gouwy et al. 2008), additional studies are needed to

443

examine the actions of chemokines as a complex cocktail rather than in isolation, as performed

444

in the present study. The current findings complement a recent review (Walusimbi & Pate 2013)

445

that postulates that immune cells in the developing and functional corpus luteum play a
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446

supportive role, but once corpus luteum regression is triggered, the immune cells promote

447

apoptosis, debris clearage and tissue remodeling. Understanding these endocrine and immune

448

events is important for increasing our ability to control reproductive function to facilitate full-term

449

pregnancies in both humans and livestock.
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660

Figure legends

661

Figure 1. Induction of chemokines following treatment with PGF in vivo and in vitro.

662

A) Midluteal phase cows were treated with saline or the PGF analogue Lutalyse (25 mg) for up

663

to 4 h. Ovaries were surgically removed and RNA was isolated from corpora lutea. Quantitative

664

real-time PCR was performed. Results are shown as means ± SEM, n = 3. B) To determine

665

the cellular signaling pathway leading to the induction of IL8 mRNA, bovine steroidogenic luteal

666

cells were pre-treated for 60 min with vehicle, the ERK1/2 inhibitor U0126 (20 µM), the p38

667

MAPK inhibitor SB207580 (10 µM) or the JNK inhibitor SP600125 (20 µM). Luteal cells were

668

then treated with control media (open bars) or PGF (100 nM, solid bars) for 60 min.

669

Quantitative real-time PCR for IL8 mRNA was performed. Results are shown as means ± SEM,

670

n = 3. *, P < 0.05; **, P < 0.01; ns, not significant .

671
672

Figure 2. Stimulatory effects of IL8 on neutrophils. A) Bovine neutrophils were isolated as

673

described in the Methods. Shown is an H&E stain of the purified bovine neutrophils used in the

674

chemotaxis assay. Neutrophils (105 cells) were placed in the upper chamber of a Boyden

675

apparatus and control media or IL8 (30 ng/ml) was placed in the lower chamber. Cell numbers

676

in the lower chamber were quantified at various intervals. B) Control media (Control), IL8 (30

677

ng/ml) or PGF (100 nM) was added to the lower chamber and migration of bovine neutrophils

678

was determined after 18 h. Results are shown as means ± SEM, n = 3. *, P < 0.05, vs Control.

679

C) Control media (Control), IL8 (30 ng/ml), PGF (100 nM), TNF (10 ng/ml) or TGFB1 (1 ng/ml)

680

was added to the lower chamber and migration of bovine neutrophils was determined after 3 h.

681

Results are shown as means ± SEM, n = 4 for CTL, IL8, PGF and n=2 for TNF and TGFB1. *,

682

P < 0.05, vs. Control.

683
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684

Figure 3. IL8 stimulates early signaling responses in bovine neutrophils. A) Bovine

685

neutrophils were treated without or with IL8 (30 ng/ml) or TNF (10 ng/ml) for 15 or 120 min to

686

identify early cell signaling responses. Western blot analysis was performed using phospho-

687

specific antibodies for ERK, p38 and JNK MAPKs, AKT, and p65 NFκB. B-actin served as a

688

loading control. B) Cells were treated as above and quantitative analysis of phospho-ERK

689

signaling is shown as means ± SEM, n = 4.

690
691

Figure 4. IL8 stimulated neutrophil migration is independent of ERK signaling. A)

692

Neutrophils were pre-treated for 60 min with vehicle or the ERK1/2 inhibitor U0126 (5 µM) prior

693

to treatment for 15 or 60 min with IL8 (30 ng/ml). Western blot analysis was performed for ERK

694

and phospho-ERK. B-actin served as a loading control. B) Neutrophils were placed in a

695

Boydon chamber and pre-treated for 60 min with vehicle or U0126 (5 µM) prior to treatment with

696

IL8 (30 ng/ml). Neutrophil migration was determined after 24 h. Results are shown as means ±

697

SEM, n = 3.

698
699

Figure 5. IL8 and neutrophils do not inhibit luteal progesterone production. A)

700

Steroidogenic luteal cells were pretreated with increasing amounts of IL8 (0-30 ng/ml) for 30 min

701

and then treated without (Control) or with LH (10 ng/ml) for 4 h. Progesterone in the media was

702

measured by RIA. Results are shown as means ± SEM, n = 4. B) Steroidogenic luteal cells

703

were co-cultured with bovine neutrophils or activated bovine neutrophils as described in the

704

Methods. Cells were then treated without (Control) or with LH (10 ng/ml) for 4 h. Progesterone

705

in the media was measured by RIA. Results are shown as means ± SEM, n = 3. *, P < 0.05, vs

706

Control; ns, not significant.

707
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708

Figure 6. Co-cultures of luteal cells with activated peripheral blood mononuclear cells

709

(PBMCs) inhibit luteal progesterone production. Steroidogenic luteal cells were co-cultured

710

with bovine PBMCs or activated PBMCs as described in the Methods. Cells were then treated

711

without (Control) or with LH (10 ng/ml) for 4 h. Progesterone in the media was measured by

712

RIA. Results are shown as means ± SEM, n = 4. Bars with different letters are significantly

713

different, P < 0.05; ns, not significant.
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Table 1. Bovine primers for qPCR.
Gene Name

Primers for qPCR

ACTB-F

ACACCGCAACCAGTTCGCCAT

ACTB-R

AAGACGGCCCGGGGAGCATC

IL8-F

TGTGAAGCTGCAGTTCTGTCAAG

IL8-R

TGCACCCACTTTTCCTTGGGGT

GAPDH-F

AGATGGTGAAGGTCGGAGTG

GAPDH-R

GATCTCGCTCCTGGAAGATG

CCL2-F

TGCTCGCTCAGCCAGATGCAAT

CCL2-R

GGACACTTGCTGCTGGTGACTCT

bCCL8-F

TCTCAGGCTGAAGCCCCCGT

CCL8-R

ACTGAATCTGGCTGAGCGAGCA

CXCL2-F

GCGCCCGTGGTCAACGAACT

CXCL2-R

AGACTGGCTATGACTTCGGTTTGGT
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Table 2. Antibodies used for cell signaling, western blots, and flow analysis
Antibody
VE-cadherin
StAR
3β-HSD
P450scc
Prolyl 4-hydroxylase
Collagen 1
Phospho ERK1/2
Phospho p38
Phospho JNK
Phospho AKT
Phospho P65-NFκB
IκBα
B-Actin

Vendor
Pierce
Douglas Stocco, PhD
Ian Mason, PhD
Millipore
Acris
Rockland Monoclonal
Cell Signaling
Cell Signaling
Santa Cruz
Cell Signaling
Cell Signaling
Santa Cruz
Sigma Aldrich

Rockford, IL
Texas Tech Univ
Dallas, TX
Danvers, MA
Brisbane, QLD
Gilbertsville, PA
Danvers, MA
Danvers, MA
Santa Cruz, CA
Danvers, MA
Danvers, MA
Santa Cruz, CA
St. Louis, MO

